Publications (231) Rafael López López publications

2024

  1. Biomarkers for Pre-Treatment Risk Stratification of Prostate Cancer Patients: A Systematic Review

    Cancers, Vol. 16, Núm. 7

  2. Cost-Utility Analysis of Adjuvant Olaparib for Germline BRCA1/2-Mutated, High-Risk HER2-Negative Early Breast Cancer in Spain

    PharmacoEconomics - Open, Vol. 8, Núm. 6, pp. 887-896

  3. DNA methylation markers for oral cancer detection in non- and minimally invasive samples: a systematic review

    Clinical Epigenetics, Vol. 16, Núm. 1

  4. Enhancing patient outcomes: Integrating electronic cardiology consultation in primary care for cancer patients

    European Journal of Clinical Investigation, Vol. 54, Núm. 8

  5. Evaluation of the clinical use of MGMT methylation in extracellular vesicle-based liquid biopsy as a tool for glioblastoma patient management

    Scientific Reports, Vol. 14, Núm. 1

  6. Exercise-based cardio-oncology rehabilitation for cardiotoxicity prevention during breast cancer chemotherapy: The ONCORE randomized controlled trial

    Progress in Cardiovascular Diseases, Vol. 85, pp. 74-81

  7. First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN

    Breast Cancer Research and Treatment, Vol. 206, Núm. 2, pp. 317-328

  8. Genome-wide DNA methylation profiling in tongue squamous cell carcinoma

    Oral Diseases, Vol. 30, Núm. 2, pp. 259-271

  9. Identification of a Proteomic Signature for Predicting Immunotherapy Response in Patients With Metastatic Non-Small Cell Lung Cancer

    Molecular and Cellular Proteomics, Vol. 23, Núm. 10

  10. Improving quality of care by standardising patient data collection in electronic medical records in an oncology department in Spain

    BMJ Open Quality, Vol. 13, Núm. 2

  11. Indicators to evaluate quality of care in head and neck cancer in Spain

    Clinical and Translational Oncology, Vol. 26, Núm. 5, pp. 1089-1097

  12. Liquid Biopsies Based on Cell-Free DNA Integrity as a Biomarker for Cancer Diagnosis: A Meta-Analysis

    Diagnostics, Vol. 14, Núm. 14

  13. Meta-analysis of genome-wide association studies for cancer therapy-related cardiovascular dysfunction and functional mapping highlight an intergenic region close to TP63

    Scientific Reports, Vol. 14, Núm. 1

  14. Oral specimens as a tool for accurate metagenomic analysis: A pilot study

    Journal of Stomatology, Oral and Maxillofacial Surgery, Vol. 125, Núm. 5

2023

  1. Agitación psicomotriz y conducta agresiva en urgencias pediátricas

    Revista de Psiquiatría Infanto-Juvenil, Vol. 40, Núm. 1, pp. 4-12

  2. Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNÚ-1 and Phase II VISNÚ-2 Randomized Trials

    Clinical Colorectal Cancer, Vol. 22, Núm. 2, pp. 222-230

  3. Clinical, molecular, and immune correlates of the Immunotherapy Response Score in patients with advanced urothelial carcinoma under atezolizumab monotherapy: analysis of the phase II IMvigor210 trial

    ESMO Open, Vol. 8, Núm. 4

  4. Effect of capmatinib on the pharmacokinetics of substrates of CYP3A (midazolam) and CYP1A2 (caffeine) in patients with MET-dysregulated solid tumours

    British Journal of Clinical Pharmacology, Vol. 89, Núm. 3, pp. 1046-1055

  5. Effectiveness of a novel gene nanotherapy based on putrescine for cancer treatment

    Biomaterials Science, Vol. 11, Núm. 12, pp. 4210-4225

  6. Epigenomic reprogramming of therapy-resistant circulating tumor cells in colon cancer

    Frontiers in Cell and Developmental Biology, Vol. 11